Our study revealed that knockdown of ANXA10 inhibited the degradation of TFRC, resulting in a significant increase in intracellular Fe2+ concentration and inducing ferroptosis in CRC cells. The gene discussed is ANXA10; the disease is colorectal carcinoma.